Alexandria Real Estate Equities, Inc. Announces Tax Treatment Of Year 2012 Distributions

Jan 31, 2013, 08:30 ET from Alexandria Real Estate Equities, Inc.

PASADENA, Calif., Jan. 31, 2013 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced today the tax treatment of its Year 2012 distributions as described in the chart below. Shareholders are encouraged to consult with their own tax advisors as to their specific tax treatment of Alexandria Real Estate Equities, Inc. distributions.

 

 Dividends

 Capital Gains

Ticker Symbol

Record Date

Payment Date

 Distribution Per Share

 Taxable Ordinary

 Qualified (1)

Total Capital Gain

Unrecaptured Section 1250 (2)

Return of

Capital (3)

   ARE

12/30/11

1/17/12

$       0.490000

$      0.416500

$                    −

$       0.050960

$                    −

$       0.022540

   ARE

3/30/12

4/13/12

0.490000

0.416500

0.050960

0.022540

   ARE

6/29/12

7/16/12

0.510000

0.433500

0.053040

0.023460

   ARE

9/28/12

10/15/12

0.530000

0.450500

0.055120

0.024380

Total Common Stock (Cusip # 015271109)

$       2.020000

$      1.717000

$                    −

$       0.210080

$                    −

$       0.092920

Percentage

100.0%

85.0%

0.0%

10.4%

0.0%

4.6%

   ARE−C

12/30/11

1/17/12

$       0.523438

$      0.466383

$                    −

$       0.057055

$                    −

$                    −

   ARE−C

3/30/12

4/13/12

0.523438

0.466383

0.057055

Total Series C Preferred Stock (Cusip # 015271406)

$       1.046875

$      0.932766

$                    −

$       0.114109

$                    −

$                    −

Percentage

100.0%

89.1%

0.0%

10.9%

0.0%

0.0%

   N/A

12/30/11

1/17/12

$       0.437500

$      0.389813

$                    −

$       0.047688

$                    −

$                    −

   N/A

3/30/12

4/13/12

0.437500

0.389813

0.047688

   N/A

6/29/12

7/16/12

0.437500

0.389813

0.047688

   N/A

9/28/12

10/15/12

0.437500

0.389813

0.047688

Total Series D Preferred Stock (Cusip # 015271505)

$       1.750000

$      1.559250

$                    −

$       0.190750

$                    −

$                    −

Percentage

100.0%

89.1%

0.0%

10.9%

0.0%

0.0%

   ARE−E

6/29/12

7/16/12

$       0.537500

(4)

$      0.478913

$                    −

$       0.058588

$                    −

$                    −

   ARE−E

9/28/12

10/15/12

0.403125

0.359184

0.043941

Total Series E Preferred Stock (Cusip # 015271703)

$       0.940625

$      0.838097

$                    −

$       0.102528

$                    −

$                    −

Percentage

100.0%

89.1%

0.0%

10.9%

0.0%

0.0%

(1) Qualified dividends are a subset of, and included in, the taxable ordinary dividend amount.

(2) Unrecaptured section 1250 gain is a subset of, and included in, the total capital gain amount.

(3) Represents a return of shareholder investment.

(4) Represents a dividend for the period beginning on the Series E Preferred Stock issuance date of March 15, 2012, and ending on July 14, 2012.

 

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed real estate investment trust ("REIT"), is the largest and leading investment-grade REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations, including Greater Boston, San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria's high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States ("U.S") government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity and innovation through its best-in-class laboratory and office space, collaborative locations adjacent to leading academic and medical institutions, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community, which we believe result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria Real Estate Equities, Inc., please visit www.are.com.

 

SOURCE Alexandria Real Estate Equities, Inc.



RELATED LINKS

http://www.are.com